# Gut microbiota diversity is altered in a sex-dependent manner in Shank3B heterozygote mice

## TL;DR

This study shows that gut bacteria diversity changes differently in male and female mice with a Shank3B gene mutation, which is linked to autism and schizophrenia.

## Contribution

The study reveals sex-specific alterations in gut microbiota diversity in Shank3B heterozygote mice, suggesting potential therapeutic targets for neurodevelopmental disorders.

## Key findings

- Shank3B+/- males show increased biodiversity and higher abundance of Staphylococcaceae and Erysipelotricaceae.
- Shank3B+/- females show reduced biodiversity compared to wild-type controls.
- Firmicutes and Lactobacillales dominate in Shank3B+/- mice gut microbiota.

## Abstract

The gut-brain axis is a dynamic interface that has been implicated in the pathogenesis and severity of various neurodevelopmental disorders such as schizophrenia (SZ) and autism spectrum disorders (ASD). Also implicated in ASD and SZ, SHANK3B is a critical gene for postsynaptic protein scaffolding at excitatory synapses. Shank3B knockout mice not only exhibit ASD-like behaviors but demonstrate altered gastrointestinal epithelium morphology and fecal microbiota composition. Utilizing Shank3B heterozygote mice to better reflect the clinical presentation of ASD, we sequenced the gut microbiome from the small intestine of 12-week-old wild type Shank3B+/+ or Shank3B+/- mice in a sex-dependent manner, analyzing bacterial phyla, classes, orders, families, genera, and species. Firmicutes emerged as the dominant phylum in Shank3B+/- mice and Bacilli as the dominant class, with Lactobacillales as the dominant order. The dominant family is Lactobacillaceae. The Shank3B+/- males but not the Shank3B+/- females show an increase in Staphylococcaceae and Erysipelotricaceae. Our results indicate increased biodiversity in Shank3B+/- males and reduced biodiversity in Shank3B+/- females compared to wild-type controls. Altogether, this data reveals sex-specific microbial signatures that may contribute to the pathogenesis of ASD thus providing potential therapeutics that target gut microbiota in neurodevelopmental disorders.